corticosterone has been researched along with Fatigue Syndrome, Chronic in 6 studies
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "05) the increase in immobility period, anxiety, spleen weight, BUN and LDH levels, and MDA levels along with decrease in grip strength, locomotor activity, plasma corticosterone, adrenal gland weight, catalase, and GSH." | 3.83 | Investigation of the effects of vanilloids in chronic fatigue syndrome. ( Goswami, S; Sarvaiya, K, 2016) |
| "One of the main mechanisms of chronic fatigue syndrome development involves disturbances of interaction between the immune and neuroendocrine systems." | 1.35 | [Cellular and molecular mechanisms of interaction between the neuroendocrine and immune systems under chronic fatigue syndrome in experiment]. ( Fomicheva, EE; Korneva, EA; Rybakina, EG; Shanin, SN, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filatenkova, TA | 3 |
| Dmitrienko, EV | 1 |
| Fomicheva, EE | 4 |
| Shanin, SN | 2 |
| Rybakina, EG | 4 |
| Sarvaiya, K | 1 |
| Goswami, S | 1 |
| Korneva, EA | 1 |
| Surapaneni, DK | 1 |
| Adapa, SR | 1 |
| Preeti, K | 1 |
| Teja, GR | 1 |
| Veeraragavan, M | 1 |
| Krishnamurthy, S | 1 |
6 other studies available for corticosterone and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
[Impairments of rats' behavioral reactions, concentration of corticosterone and expression of cytokine's gene under experimental postviral fatigue].
Topics: Animals; Corticosterone; Disease Models, Animal; Fatigue Syndrome, Chronic; Gene Expression; Hypotha | 2014 |
Investigation of the effects of vanilloids in chronic fatigue syndrome.
Topics: Animals; Anxiety; Brain; Capsaicin; Corticosterone; Disease Models, Animal; Fatigue Syndrome, Chroni | 2016 |
[Activity of hypotnalamic-pituitary-adrenal axis by induction of experimental chronic fatigue syndrom].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Cold Temperature; Co | 2009 |
[Cellular and molecular mechanisms of interaction between the neuroendocrine and immune systems under chronic fatigue syndrome in experiment].
Topics: Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Antiviral Agents; Cell Membrane; Cor | 2009 |
Activity in the hypothalamo-hypophyseal-adrenocortical system on experimental induction of chronic fatigue syndrome.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Cold Temperature; Co | 2010 |
Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
Topics: Adrenal Glands; Animals; Antioxidants; Anxiety; Behavior, Animal; Behavioral Symptoms; Benzopyrans; | 2012 |